Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T14:17:29.169Z Has data issue: false hasContentIssue false

Chapter 15 - Management of sleep disorders in Parkinson's disease

from Section II - Management of Nonmotor Symptoms of Parkinson's Disease

Published online by Cambridge University Press:  05 March 2016

By
Daniela Calandrella  and
Alberto Albanese
Edited by
Néstor Gálvez-Jiménez ,
Hubert H. Fernandez ,
Alberto J. Espay  and
Susan H. Fox
Néstor Gálvez-Jiménez
Affiliation:
Cleveland Clinic, Florida
Hubert H. Fernandez
Affiliation:
Cleveland Clinic, Ohio
Alberto J. Espay
Affiliation:
University of Cincinnati
Susan H. Fox
Affiliation:
Toronto Western Hospital
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Parkinson's Disease
Current and Future Therapeutics and Clinical Trials
 , pp. 151 - 161
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dickson, DW, Fujishiro, H, Orr, C, et al. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 2009; 15 (Suppl. 3): S1–5.Google Scholar
Iranzo, A. Parkinson disease and sleep: sleep–wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features. Curr Neurol Neurosci Rep 2013; 13: 373.CrossRefGoogle ScholarPubMed
Tolosa, E, Gaig, C, Santamaria, J, Compta, Y. Diagnosis and the premotor phase of Parkinson disease. Neurology 2009; 72 (Suppl.): S12–20.Google ScholarPubMed
Boeve, BF. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol 2013; 12: 469–82.Google Scholar
Louter, M, Aarden, WC, Lion, J, Bloem, BR, Overeem, S. Recognition and diagnosis of sleep disorders in Parkinson's disease. J Neurol 2012; 259: 2031–40.Google Scholar
Lees, AJ, Blackburn, NA, Campbell, VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988; 11: 512–9.Google Scholar
Zoccolella, S, Savarese, M, Lamberti, P, et al. Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011; 15: 41–50.Google Scholar
Comella, CL. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007; 22 (Suppl. 17): S367–73.Google Scholar
Chaudhuri, KR, Logishetty, K. Dopamine receptor agonists and sleep disturbances in Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl. 4): S101–4.CrossRefGoogle ScholarPubMed
Oerlemans, WG, de Weerd, AW. The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey. Sleep Med 2002; 3: 147–9.Google Scholar
Videnovic, A, Golombek, D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol 2013; 243: 45–56.CrossRefGoogle ScholarPubMed
Iranzo, A. Sleep–wake changes in the premotor stage of Parkinson disease. J Neurol Sci 2011; 310: 283–5.Google Scholar
Menza, M, Dobkin, RD, Marin, H, Bienfait, K. Sleep disturbances in Parkinson's disease. Mov Disord 2010; 25 (Suppl. 1): S117–22.Google Scholar
Schenck, CH, Bundlie, SR, Ettinger, MG, Mahowald, MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986; 9: 293–308.CrossRefGoogle ScholarPubMed
Comella, CL, Nardine, TM, Diederich, NJ, Stebbins, GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998; 51: 526–9.Google Scholar
Montplaisir, J, Gagnon, JF, Fantini, ML, et al. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 2010; 25: 2044–51.Google Scholar
Nielsen, T, Svob, C, Kuiken, D. Dream-enacting behaviors in a normal population. Sleep 2009; 32: 1629–36.Google Scholar
Gagnon, JF, Bedard, MA, Fantini, ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59: 585–9.CrossRefGoogle ScholarPubMed
Iranzo, A, Molinuevo, JL, Santamaria, J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572–7.CrossRefGoogle ScholarPubMed
Iranzo, A, Valldeoriola, F, Lomena, F, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2011; 10: 797–805.Google Scholar
Stockner, H, Iranzo, A, Seppi, K, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2009; 24: 1906–9.Google Scholar
McCarter, SJ, Boswell, CL, St Louis, EK, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med 2013; 14: 237–42.Google Scholar
Allen, RP, Picchietti, D, Hening, WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101–19.Google Scholar
Garcia-Borreguero, D, Egatz, R, Winkelmann, J, Berger, K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10: 153–67.Google Scholar
Lugaresi, E, Coccagna, G, Gambi, D, Berti, CG, Poppi, M. Symonds’ nocturnal myoclonus. Electroencephalogr Clin Neurophysiol 1967; 23: 289.Google Scholar
PoeweW, Högl B. Akathisia, , restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004; 63 (Suppl. 3): S12–16.Google Scholar
Baumann, CR, Marti, I, Bassetti, CL. Restless legs symptoms without periodic limb movements in sleep and without response to dopaminergic agents: a restless legs-like syndrome? Eur J Neurol 2007; 14: 1369–72.CrossRefGoogle ScholarPubMed
Chotinaiwattarakul, W, Dayalu, P, Chervin, RD, Albin, RL. Risk of sleep-disordered breathing in Parkinson's disease. Sleep Breath 2011; 15: 471–8.Google Scholar
Arnulf, I, Konofal, E, Merino-Andreu, M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002; 58: 1019–24.Google Scholar
Cochen de Cock, V, Abouda, M, Leu, S, et al. Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 2010; 11: 247–52.Google Scholar
Trotti, LM, Bliwise, DL. No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord 2010; 25: 2246–9.Google Scholar
Tandberg, E, Larsen, JP, Karlsen, K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999; 14: 922–7.Google Scholar
Tan, EK, Lum, SY, Fook-Chong, SM, et al. Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology 2002; 58: 465–8.Google Scholar
Razmy, A, Lang, AE, Shapiro, CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97–102.Google Scholar
Ondo, WG, Dat, VK, Khan, H, et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001; 57: 1392–6.Google Scholar
Frucht, S, Rogers, JD, Greene, PE, Gordon, MF, Fahn, S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908–10.Google Scholar
Paus, S, Brecht, HM, Koster, J, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003; 18: 659–67.Google Scholar
Chaudhuri, KR. The dopaminergic basis of sleep dysfunction and non motor symptoms of Parkinson's disease: evidence from functional imaging. Exp Neurol 2009; 216: 247–8.Google Scholar
Monti, JM, Jantos, H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 2008; 172: 625–46.Google Scholar
Grinberg, LT, Rueb, U, Alho, AT, Heinsen, H. Brainstem pathology and non-motor symptoms in PD. J Neurol Sci 2010; 289: 81–8.Google Scholar
Monti, JM, Monti, D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 2007; 11: 113–33.Google Scholar
Garcia-Lorenzo, D, Longo-Dos, SC, Ewenczyk, C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain 2013; 136): 2120–9.Google Scholar
Lu, J, Jhou, TC, Saper, CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 2006; 26: 193–202.Google Scholar
Suzuki, K, Miyamoto, M, Miyamoto, T, Iwanami, M, Hirata, K. Sleep disturbances associated with Parkinson's disease. Parkinsons Dis 2011; 2011: 219056.Google Scholar
Happe, S, Baier, PC, Helmschmied, K, et al. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease. J Neurol 2007; 254: 1037–43.Google Scholar
Iranzo, A, Lomena, F, Stockner, H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 2010; 9: 1070–7.Google Scholar
Witkovsky, P. Dopamine and retinal function. Doc Ophthalmol 2004; 108: 17–40.Google Scholar
Boeve, BF, Silber, MH, Saper, CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130: 2770–88.Google Scholar
Scherfler, C, Frauscher, B, Schocke, M, et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 2011; 69: 400–7.Google Scholar
Diederich, NJ, McIntyre, DJ. Sleep disorders in Parkinson's disease: many causes, few therapeutic options. J Neurol Sci 2012; 314: 12–9.CrossRefGoogle ScholarPubMed
Chaudhuri, KR, Prieto-Jurcynska, C, Naidu, Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 704–9.Google Scholar
Högl, B, Arnulf, I, Comella, C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 2010; 25: 2704–16.Google Scholar
Zesiewicz, TA, Sullivan, KL, Arnulf, I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2010; 74: 924–31.Google Scholar
Ferreira, JJ, Katzenschlager, R, Bloem, BR, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol 2013; 20: 5–15.CrossRefGoogle ScholarPubMed
Chaudhuri, KR, Schapira, AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464–74.Google Scholar
Leeman, AL, O’Neill, CJ, Nicholson, PW, et al. Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987; 24: 637–43.Google Scholar
Stocchi, F, Barbato, L, Nordera, G, Berardelli, A, Ruggieri, S. Sleep disorders in Parkinson's disease. J Neurol 1998; 245 (Suppl. 1): S15–18.Google Scholar
Comella, CL, Morrissey, M, Janko, K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005; 64: 1450–1.CrossRefGoogle ScholarPubMed
Reuter, I, Ellis, CM, Ray, CK. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999; 100: 163–7.Google Scholar
Poewe, WH, Rascol, O, Quinn, N, et al. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 2007; 6: 513–20.Google Scholar
Pahwa, R, Stacy, MA, Factor, SA, et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 2007; 68: 1108–15.Google Scholar
Romigi, A, Stanzione, P, Marciani, MG, et al. Effect of cabergoline added to levodopa treatment on sleep–wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study. J Neural Transm 2006; 113: 1909–13.Google Scholar
Högl, B, Rothdach, A, Wetter, TC, Trenkwalder, C. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003; 28: 1866–70.Google Scholar
Trenkwalder, C, Kies, B, Rudzinska, M, et al. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011; 26: 90–9.CrossRefGoogle ScholarPubMed
Takanashi, M, Shimo, Y, Hatano, T, Oyama, G, Hattori, N. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study. Drug Res (Stuttg) 2013; 63: 639–43.Google ScholarPubMed
Dowling, GA, Mastick, J, Colling, E, et al. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med 2005; 6: 459–66.Google Scholar
Medeiros, CA, Carvalhedo de Bruin, PF, Lopes, LA, et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol 2007; 254: 459–64.Google Scholar
Abe, K, Hikita, T, Sakoda, S. [A hypnotic drug for sleep disturbances in patients with Parkinson's disease]. No To Shinkei 2005; 57: 301–5 (in Japanese).Google Scholar
Juri, C, Chana, P, Tapia, J, Kunstmann, C, Parrao, T. Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol 2005; 28: 185–7.Google Scholar
Linazasoro, G, Marti Masso, JF, Suarez, JA. Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Mov Disord 1993; 8: 171–4.Google Scholar
Seppi, K, Weintraub, D, Coelho, M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011; 26 (Suppl. 3): S42–80.CrossRefGoogle ScholarPubMed
Dresler, M, Spoormaker, VI, Beitinger, P, et al. Neuroscience-driven discovery and development of sleep therapeutics. Pharmacol Ther 2013; 141: 300–4.Google Scholar
Rios, RS, Creti, L, Fichten, C, et al. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – a randomized study. Parkinsonism Relat Disord 2013; 19: 670–5.Google Scholar
Morgenthaler, T, Kramer, M, Alessi, C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine Report. Sleep 2006; 29: 1415–19.Google Scholar
Iranzo, A, Santamaria, J, Rye, DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005; 65: 247–52.CrossRefGoogle ScholarPubMed
Olson, EJ, Boeve, BF, Silber, MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331–9.Google Scholar
Schmidt, MH, Koshal, VB, Schmidt, HS. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med 2006; 7: 418–23.Google Scholar
Kumru, H, Iranzo, A, Carrasco, E, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep 2008; 31: 1418–21.Google Scholar
Antonini, A, Tesei, S, Zecchinelli, A, et al. Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life. Mov Disord 2006; 21: 1119–22.Google Scholar
Kunz, D, Mahlberg, R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 2010; 19: 591–6.Google Scholar
Kotagal, V, Albin, RL, Muller, ML, et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 2012; 71: 560–8.Google Scholar
Nomura, T, Kawase, S, Watanabe, Y, Nakashima, K. Use of ramelteon for the treatment of secondary REM sleep behavior disorder. Intern Med 2013; 52: 2123–6.Google Scholar
Trotti, LM, Bliwise, DL. Treatment of the sleep disorders associated with Parkinson's disease. Neurotherapeutics 2013; 11: 68–77.Google Scholar
Howell, MJ, Arneson, PA, Schenck, CH. A novel therapy for REM sleep behavior disorder (RBD). J Clin Sleep Med 2011; 7: 639–644A.Google Scholar
Bruin, VM, Bittencourt, LR, Tufik, S. Sleep–wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions. Eur Neurol 2012; 67: 257–67.CrossRefGoogle ScholarPubMed
Giles, TL, Lasserson, TJ, Smith, BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; CD001106.Google Scholar
Högl, B, Saletu, M, Brandauer, E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002; 25: 905–9.Google Scholar
Adler, CH, Caviness, JN, Hentz, JG, Lind, M, Tiede, J. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003; 18: 287–93.Google Scholar
Ondo, WG, Fayle, R, Atassi, F, Jankovic, J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005; 76: 1636–9.Google Scholar
Devos, D, Krystkowiak, P, Clement, F, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 470–5.Google Scholar
Postuma, RB, Lang, AE, Munhoz, RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology 2012; 79: 651–8.Google Scholar
O'suilleabhain, PE, Dewey, RB Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002; 59: 986–9.Google Scholar
Breen, DP, Williams-Gray, CH, Mason, SL, Foltynie, T, Barker, RA. Excessive daytime sleepiness and its risk factors in incident Parkinson's disease. J Neurol Neurosurg Psychiatry 2013; 84: 233–4.Google Scholar
Fasano, A, Daniele, A, Albanese, A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 2012; 11: 429–42.Google Scholar
Monaca, C, Ozsancak, C, Jacquesson, JM, et al. Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease. J Neurol 2004; 251: 214–8.Google Scholar
Iranzo, A, Valldeoriola, F, Santamaria, J, Tolosa, E, Rumia, J. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 661–4.Google Scholar
Arnulf, I, Bejjani, BP, Garma, L, et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000; 55: 1732–4.Google Scholar
Hjort, N, Ostergaard, K, Dupont, E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004; 19: 196–9.Google Scholar
Lyons, KE, Pahwa, R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg 2006; 104: 502–5.Google Scholar
Chahine, LM, Ahmed, A, Sun, Z. Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord 2011; 17: 208–11.Google Scholar
Driver-Dunckley, E, Evidente, VG, Adler, CH, et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006; 21: 1287–9.Google Scholar
Kedia, S, Moro, E, Tagliati, M, Lang, AE, Kumar, R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004; 63: 2410–12.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×